New Disease and Therapy Review on Melanoma Features Chapters on Treatment, Dosing and Treatment...

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c56907) has announced the addition of Disease and Therapy Review: Melanoma to their offering.

The Melanoma Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries
worldwide. Information on disease risk factors, identification, and staging, are also provided. Treatments options such as surgery, chemotherapy, radiation therapy, immunotherapy, and gene therapy are discussed. Dosing and treatment cost information is provided for the three approved melanoma treatments (Intron-A, Proleukin, and DTIC-Dome). The worldwide melanoma market size and sales data for Proleukin and Intron-A